Cart 10 items $1622.83
Your cart
Vasotec Vasotec 2,5 mg x 360 pills $ 150.48 $ 150.48
Sildalis Sildalis 100/20 mg x 60 pills $ 93.60 $ 93.60
Update 60 pills to 90 pills and save $ 64.80
Lamictal Lamictal 200 mg x 60 pills $ 187.80 $ 187.80
Update 60 pills to 90 pills and save $ 99.00
Trandate Trandate 50 mg x 180 pills $ 126.54 $ 126.54
Sumycin Sumycin 250 mg x 30 pills $ 14.40 $ 14.40
Update 30 pills to 60 pills and save $ 4.80
Sustiva Sustiva 200 mg x 120 pills $ 352.80 $ 352.80
Venlafaxine Venlafaxine 75 mg x 10 pills $ 19.99 $ 19.99
Update 10 pills to 30 pills and save $ 11.10
Diltiazem Diltiazem 90 mg x 360 pills $ 396.72 $ 396.72
Lamictal Lamictal 200 mg x 90 pills $ 252.90 $ 252.90
Vasotec Vasotec 2,5 mg x 30 pills $ 27.60 $ 27.60
Update 30 pills to 60 pills and save $ 10.80
1 FREE FREE  
Shipping method:
Free  
Pay at our secure server: $ 1622.83  
Our discount gifts for all reliable consumers:
10% Discount for all next orders 10% discount for all next orders
Free standard airmail service for all orders with sum starting at $200.00 Free standard airmail service for all orders with sum starting at $200
Testimonials
David Rochester, Oxford-United Kingdom
Hi, I’m pleased to tell you my order arrived yesterday. Many thanks for you help!
read more»
Phil, Los Angeles
Very good company to deal with, the delivery over here in USA was very Quick, will certainly deal with them in the future.
read more»
News
Cost of children's homes doubles but care can be poor, says report
Huge sums spent on children's residential care in England do not represent value for money, says spending watchdog.
What the NHS can learn from the European country that helped more people survive cancer
Denmark's survival rates record for certain cancers were poor compared to some other wealthy countries. Then it came up with a bold plan
Doctors warn hospitals under pressure as NHS waiting lists rise
The waiting list for planned hospital treatment in England rose for the second month in a row in July to its highest level since March.
Postcode lottery for new cancer treatments, doctors warn
Experts say bureaucracy is "stifling innovation" and that applying for funding to pay for new treatments can be "cumbersome".
Shipping Option